BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, January 13, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

April 1, 2020

View Archived Issues
ABM-respiratory-biwaze-cough-system.png

FDA nod for ABM Respiratory Care’s Biwaze Cough system

Charleston, S.C.-based startup ABM Respiratory Care has received U.S. FDA clearance for its first product, an airway clearance system known as Biwaze Cough. The portable device helps to remove secretions for people who are unable to cough or clear away secretions effectively on their own due to injury or disease. Read More
Radlogics-corona-score.png

CT scans interpreted by AI can help diagnose coronavirus

An artificial intelligence-based system can accurately detect COVID-19 using thoracic CT scans in patients with respiratory symptoms, according to a preprint study published on arXiv.org. The system can also help monitor patients with the disease. Other teams have employed AI to speed diagnosis and develop clarity on the signature appearance of the disease in the lungs of symptomatic patients. Read More
Cerus-plasma-lab.png

Cerus looks to optimize convalescent plasma therapy

Cerus Corp., of Concord, Calif., is teaming up with several collaborators in its home state, with an eye toward optimizing convalescent plasma therapy for COVID-19 patients. Read More
Oncosil-CEO-Kenny.png

Oncosil wins CE mark, breakthrough designation for pancreatic cancer device

PERTH, Australia – The British Standards Institute (BSI) granted Sydney-based Oncosil Medical Ltd. European CE marking approval for its brachytherapy device to treat locally advanced pancreatic cancer in combination with chemotherapy, clearing the way for marketing in both the EU and the U.K. BSI also granted the Oncosil device breakthrough therapy designation. Read More
sepsis-bacteria-blood.png

Sepsis study may yield new treatment strategies

Indian scientists have discovered a previously unknown mechanism underlying life-threatening sepsis and proposed a new treatment strategy centered upon cell-free chromatin (cfCh), they reported in the March 4, 2020, edition of PLOS ONE. Notably, they showed that sepsis could be caused by cfCh released from dying host cells following microbial infection. Read More

Appointments and advancements for April 1, 2020

New hires and promotions in the med-tech industry, including: Microbot Medical. Read More

Financings for April 1, 2020

Med-tech firms raising money in public or private financings, including: Cellfe, Genetic Technologies, Heart Health Intelligence. Read More

In the clinic for April 1, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Bioscience. Read More

Other news to note for April 1, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 1drop, Bactiguard Holding, Bat-Call, Becton Dickinson, Bioiq, Biomedomics, Bioporto Diagnostics, Chembio, Essity, Flir Systems, Henry Schein, Homedoctor, Lifesignals, Luminarie, Maquestionmedicale, Masimo, Medtronic, Miradx, Nanovibronix, Nemaura, Neteera, Novioscan, Pointclickcare, One Medical, Sd Biosensor, Somatix, Stethome, Stryker, Tni Medical, Viecure, Viewray, Viscient Biosciences. Read More

Regulatory actions for April 1, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: ABM Respiratory Care, Crossbay Medical. Read More

Regulatory front for April 1, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies. Read More

BioWorld MedTech’s Orthopedics Extra for April 1, 2020

Keeping you up to date on recent developments in orthopedics, including: Individuals taking class of steroid medications at high risk for COVID-19; Broken bone location can have significant impact on long-term health; (Re)generation next: Novel strategy to develop scaffolds for joint tissue regeneration. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 12, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Icons representing scientific research

    Science in 2025: the best of the rest

    BioWorld Science
    A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing